5% stakes
Biotechnology Value Fund
Institution
- 5% stake reports
- 51
- 5% stake stocks
- 31
- Latest report
- 26/09/30
5% stake reports
| Stock | ||
|---|---|---|
| Stoke Therapeutics STOK09/30 | 5.6%3,608,968 sh | First report |
| Tyra Biosciences TYRA09/21 | 6.1%4,215,886 sh | +2.1pp |
| Alector ALEC09/18 | 8.4%9,374,267 sh | First report |
| Palvella Therapeutics PVLA08/14 | 4.7%672,789 sh | −2.4pp |
| OnKure Therapeutics OKUR08/14 | 8%3,235,778 sh | +2.7pp |
| Nektar Therapeutics NKTR08/14 | 7.1%2,391,075 sh | −2.7pp |
| Avalo Therapeutics AVTX08/14 | 5.3%2,801,545 sh | −4.7pp |
| TCGX Acquisition TCGX08/12 | 5.5%500,000 sh | First report |
| Entera Bio ENTX08/04 | 9.99%17,225,121 sh | First report |
| Research Alliance Corp IV RACD07/20 | 6.4%500,000 sh | First report |
| Pyxis Oncology PYXS07/10 | 9.99%8,336,902 sh | First report |
| MoonLake Immunotherapeutics MLTX06/29 | 19.7%16,001,284 sh | −2.6pp |
| Kymera Therapeutics KYMR06/26 | 6.3%5,237,151 sh | −2.2pp |
| Q32 Bio QTTB06/04 | 9.99%2,367,524 sh | First report |
| Research Alliance Corp III RACC05/29 | 6.4%500,000 sh | First report |
| OnKure Therapeutics OKUR05/27 | 5.3%2,134,908 sh | First report |
| Nektar Therapeutics NKTR05/15 | 9.8%2,852,698 sh | +2.4pp |
| ImageneBio IMA05/15 | 9.9%1,110,002 sh | +2.7pp |
| Compass Therapeutics CMPX05/15 | 4.3%7,764,842 sh | −0.8pp |
| MoonLake Immunotherapeutics MLTX04/02 | 22.3%16,001,284 sh | −5.4pp |
